The device is indicated for use as a dispenser, a measuring device and a fluid transfer device. It is used to deliver fluids into the body orally or enterally. It is intended to be used in clinical or home care settings by users ranging from clinicians to laypersons (under the supervision of a clinician) in all age groups.

Device Description

NeoMed Oral/Enteral Syringes with ENFit® connector (12 mL to 100 mL) are standard piston style syringes consisting of a syringe barrel (vented or non-vented) with integral ENFit® syringe tip, syringe plunger, and syringe gasket. They are supplied in sizes ranging from 12 mL to 100 mL nominal capacity, sterile or non-sterile, with or without a syringe tip cap, and in varying colors. The integral syringe tip is a female ENFit® connector designed to be compatible only with enteral access devices or accessories having ENFit® compliant or compatible male connectors to form a dedicated system that prevents wrong-route administration of fluids.

NeoMed Low Dose Tip Oral/Enteral Syringes with ENFit® connector (0.5 mL to 6 mL) are standard piston style syringes consisting of a syringe barrel with integral ENFit® syringe tip that has the additional low dose tip design feature, syringe plunger, and syringe gasket, They are supplied in sizes ranging from 0.5 mL to 6 mL nominal capacity, sterile or nonsterile, with or without a syringe tip cap, and in varying colors. The integral syringe tip is a female ENFit® connector with the additional low dose tip design feature designed to be compatible only with enteral access devices or accessories having ENFit® compliant or compatible male connectors to form a dedicated system that prevents wrong-route administration of fluids.

AI/ML Overview

The provided text is a 510(k) summary for NeoMed Oral/Enteral Syringes with ENFit® connectors. It describes performance testing conducted but does not present specific acceptance criteria or quantitative performance data that would allow for a detailed table with reported device performance against those criteria. It lists the types of tests performed.

Therefore, I cannot provide a table of acceptance criteria and reported device performance, nor details about sample sizes, expert qualifications, or adjudication methods for a test set regarding specific performance metrics.

However, I can extract the information that is present regarding the studies:

1. A table of acceptance criteria and the reported device performance

Not explicitly provided in the document. The document lists the types of performance tests conducted (e.g., Capacity Tolerance, Graduated Scale, Air and Liquid Leakage Testing, Dosing Accuracy Testing, various ENFit® connector resistance tests) but does not state the numerical acceptance criteria or the specific performance results achieved by the device against these criteria.

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

Sample size: Not specified for any of the performance tests.
Data provenance: Not specified. The testing was conducted by the manufacturer, NeoMed, Inc., which is based in Woodstock, GA, USA. The document implies these were bench tests performed during device development.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not applicable/Not specified. The tests mentioned are primarily bench tests (e.g., dimensional verification, leakage, resistance, dosing accuracy) that rely on objective measurements rather than expert interpretation or ground truth establishment in a clinical sense. Human Factors Validation Studies and Usability Studies involved human participants, but the number or qualifications of "experts" to establish ground truth is not relevant in the context you've described.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable/Not specified. This pertains to clinical studies often involving expert interpretation of medical images or patient outcomes. The listed tests are bench performance tests.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No. An MRMC comparative effectiveness study is not mentioned. This type of study is relevant for AI/CAD systems that assist human readers in image interpretation, which is not the function of these oral/enteral syringes.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

No. This device is a medical syringe, not an algorithm or AI system.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

Objective measurement/Standards compliance. For tests like dimensional verification, capacity tolerance, leakage testing, and resistance tests, the "ground truth" is defined by the physical or engineering specifications (e.g., ISO standards, internal design specifications) against which the device performance is measured. For dosing accuracy, it would be the actual volume dispensed versus the intended volume.

8. The sample size for the training set

Not applicable. This device is a physical product, not a machine learning model that requires a training set.

9. How the ground truth for the training set was established

Not applicable. As above, it's not a machine learning model.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus, with three human profiles facing right, representing health and human services.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 17, 2016

NeoMed, Inc. Melinda Harrison Smith Director, Quality and Regulatory Affairs 100 Londonderry Ct, Suite 112 Woodstock, GA 30188

Re: K161039

Trade/Device Name: NeoConnect Oral/Enteral Syringes with ENFit Connector (12 mL to 100 mL) And NeoConnect Low Dose Tip Oral/Enteral Syringes with ENFit Connector (0.5 mL to 6 mL) Regulation Number: 21 CFR 876.5980 Regulation Name: Gastrointestinal Tube and Accessories Regulatory Class: Class II Product Code: PNR Dated: April 11, 2016 Received: April 13, 2016

Dear Melinda Smith,

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Benjamin R. Fisher -S

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K161039

Device Name

Oral/Enteral Syringes with ENFit® Connector (12 mL to 100 mL) and Low Dose Tip Oral/Enteral Syringes with ENFit® Connector (0.5 mL to 6 mL)

Indications for Use (Describe)

The device is indicated for use as a dispenser, a measuring device and a fluid transfer device. It is used to deliver fluids into the body or enterally. It is intended to be used in clinical or home care settings by users ranging from clinicians to laypersons (under the supervision of a clinician) in all age groups.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

TRADITIONAL 510(K) SUMMARY (21 CFR § 807.92)

I. SUBMITTER	NeoMed, Inc.
	100 Londonderry Court
	Suite 112
	Woodstock, GA 30188
	Tel: 770-516-2225
	Fax: 770-516-2448

Melinda Harrison Smith, RAC, CBA Contact: mharrison@neomedinc.com
- Date Prepared: 10 June 2016

Establishment 3006520777 Registration Number:

DEVICE ll.

Trade Name:

Oral/Enteral Syringes with ENFit® connector (12 mL to 100mL) and Low Dose Tip Oral/Enteral Syringes with ENFit® connector (0.5 mL to 6 mL)

Common Name:	Oral/Enteral Syringe
Classification Name:	Gastrointestinal tube and accessories (21 CFR § 876.5980)
Regulatory Class:	II
Product Code :	PNR

lll. PREDICATE DEVICE

NeoMed NeoConnect™ Enteral Syringes with ENFit™ Connector and compatible NeoSecure™ Tip Caps (K152857)

Predicate device has not been subject to a design-related recall.

IV. DEVICE DESCRIPTION

{4}------------------------------------------------

compatible male connectors to form a dedicated system that prevents wrong-route administration of fluids.

V. INDICATIONS FOR USE

VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE

Oral/Enteral Syringes with ENFit® connector (12 mL to 100mL) and Low Dose Tip Oral/Enteral Syringes with ENFit® connector (0.5 mL to 6 mL) have similar intended use and designs as well as identical principles of operation, materials, patient populations and use environments as the predicate device K152857.

VII. PERFORMACE DATA (BENCH)

The following performance testing was conducted on the Oral/Enteral Syringes with ENFit® connector and Low Dose Tip Oral/Enteral Syringes with ENFit® connector:

Finished Device
- Risk Analysis including design, user and process FMEA (Failure Modes and o Effects Analysis) in accordance with EN ISO 14971:2012
- Human Factors and Usability Validation o
- o Biocompatibility
  - ISO 10993-5: Cytotoxicity
  - ISO 10993-10: Irritation and sensitization l
  - I ISO 10993-11: Acute Toxicity
- o Chemical Testing
  - Extractables and Leachables ■
- o Finished Device Verification Testing
  - Critical Dimension verification
  - Ink Adhesion
  - I ISO 7886

{5}------------------------------------------------

Capacity Tolerance ●
. Graduated Scale
Piston Fit in Barrel ●
Air and Liguid Leakage Testing .
Direct Oral Administration Dosing Accuracy Testing .
Syringe Tip (ISO 80369-3 (ENFit®) connector) ●
- o Enteral Connector Misconnection Assessment
- Human Factors Validation Study (Standard ENFit®) o
- o Dimensional verification to ISO 80369-3
- Liquid leakage testing O
- O Resistance to stress cracking
- Resistance to separation from axial load O
- Resistance to separation from unscrewing O
- Resistance to overriding O
- Disconnection by unscrewing o
Additional Testing for Syringe Tip (ISO 80369-3 (ENFit®) connector with Low Dose ● Tip Design Feature)
- Low Dose Tip Misconnection Risk Management Reports O
- Usability Study for Low Dose Syringe Tip Design Feature O
- Low Dose ENFit® Enteral Syringe Design Dosing Accuracy Testing O
- Dimensional verification to ISO 80369-3 O
- Liquid leakage testing O
- Resistance to stress cracking O
- Resistance to separation from axial load O
- Resistance to separation from unscrewing O
- Resistance to overriding o
- Disconnection by unscrewing O

VIII. CONCLUSIONS

NeoMed Oral/Enteral Syringes with ENFit® connector (12 mL to 100mL) and Low Dose Tip Oral/Enteral Syringes with ENFit® connector (0.5 mL to 6 mL) are substantially equivalent to the NeoMed NeoConnect™ Enteral Syringes with ENFit® Connector and compatible NeoSecure™ Tip Caps (K152857).

Regulation Number and Section

§ 876.5980 Gastrointestinal tube and accessories.

(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.